Eyeing presidential poll, Congress not to field candidate against Dimple Yadav

June 5, 2012

poll

New Delhi, Jun 5: Reflecting the growing bonhomie between the two parties, Congress has decided not to field any candidate against UP Chief minister Akhilesh Yadav's wife Dimple Yadav, the Samajwadi Party candidate in the Kannauj Lok Sabha by-election.

"We had not contested the seat in the 2009 Lok Sabha election and we are not contesting it now," party General Secretary Digvijay Singh said, adding that besides Kannauj, the party had not put up candidate then from Mainpuri from where Mulayam Singh had contested.

The by-election, being held on June 24, has been necessitated following the resignation of Akhilesh Yadav after his election to the Legislative Council.

Dimple Yadav is expected to file her nomination for the Kannauj Lok Sabha constituency today.

The decision of the Congress this time is in sharp contrast to the 2009 by-election to the Firozabad Lok Sabha seat for which the party had fielded cine star Raj Babbar against Dimple, daughter-in-law of Mulayam Singh Yadav.

Babbar won the by-poll after Congress general secretary Rahul Gandhi campaigned against Dimple during her maiden entry into the political fray.

Congress and SP have been lately drawing close to each other.

Despite being an outside supporter of the government at the Centre, SP supremo Mulayam Singh Yadav's presence at the UPA's third anniversary dinner last month was reassuring for the Congress which had been plagued by frequent tantrums of some of its allies, especially Mamata Banerjee's Trinamool Congress.

At the dinner, Yadav had also declared support to the candidate which be decided by the Congress in the Presidential poll on the condition that the nominee should not be a bureaucrat.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
August 8,2020

Kozhikode, Aug 8: Minister of State (Mos) for External Affairs V Muraleedharan on Saturday reached Kozhikode where Air India Express flight (IX-1344) crash-landed yesterday. 

He is likely to meet those injured in the crash and their family members.

At least 17 people including two pilots have lost their lives in the incident. However, the four-cabin crew members are safe, said the Air India Express in a statement. 

The injured are admitted to hospitals in Malappuram and Kozhikode, as per the state government officials.

Informing about his visit to Kozhikode, Muraleedharan tweeted: "Taking off to #Calicut by @airindiain
special flight. Hope to visit the crash site at the Calicut Airport and also meet those injured in the crash and their family members."

Muraleedharan on Friday expressed grief after an Air India Express plane carrying 190 passengers including 10 infants skidded while landing at Karipur Airport in Kozhikode.

"Deeply anguished to hear about the mishap in Calicut airport involving the flight from Dubai to Calicut. Was informed that the plane overshot the runway and seemingly nosedived," the Minister tweeted.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

New Delhi, Aug 3: Afghanistan President Ashraf Ghani on Monday thanked Prime Minister Narendra Modi for the timely supply of food and medical assistance to meet the requirement in Afghanistan.

During their telephonic conversation, PM Modi also reiterated India's commitment to the people of Afghanistan in their quest for a peaceful, prosperous and inclusive Afghanistan, the Prime Minister's Office said in a statement on Monday.

The two leaders also exchanged views on the evolving security situation in the region and other areas of mutual bilateral interest.
Both leaders also exchanged greetings on Eid-Al-Adha. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.